Gayn Erickson - 12 Aug 2026 Form 4 Insider Report for AEHR TEST SYSTEMS (AEHR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Aug 2026, 18:12:32 UTC
Prior SEC filing
27 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Chris Siu, Attorney-in-Fact

Key filing fact

Gayn Erickson filed Form 4 for AEHR TEST SYSTEMS (AEHR) on 13 Aug 2026.

Key facts

  • This page summarizes Gayn Erickson's Form 4 filing for AEHR TEST SYSTEMS (AEHR).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Aug 2026, 18:12.

Change

  • Previous filing in this sequence was filed on 27 Jul 2026.
  • Current net transaction value: -$5,233,718.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001364097 Primary reporting owner

Erickson Gayn

Relationship
President and CEO, Director
Address
C/O AEHR TEST SYSTEMS, 400 KATO TERRACE, FREMONT
Signature
/s/Chris Siu, Attorney-in-Fact
Signature date
13 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AEHR transaction

Common Stock

Sale

Transaction value
$204,750
Shares
-1,548
Change %
-0.78%
Price
$132.27
Shares after
196,175
Date
12 Aug 2026
Ownership
By Trust
AEHR transaction

Common Stock

Sale

Transaction value
$5,028,968
Shares
-38,452
Change %
-20%
Price
$130.79
Shares after
157,723
Date
12 Aug 2026
Ownership
By Trust
AEHR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
197,521
Date
12 Aug 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .